Bullfrog AI Holdings Inc (BFRG)

NASD · Healthcare · Health Information Services · USA

Bullfrog AI Holdings Inc is a micro cap company (market value under $300 million) in the Health Information Services industry.

Bullfrog AI Holdings uses artificial intelligence and machine learning to advance therapeutic development through its bfLEAP platform. The company analyzes complex data from drug discovery, preclinical, and clinical development stages to improve success rates and reduce costs. It operates through internal programs and strategic partnerships with biopharmaceutical companies.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the Bullfrog AI Holdings Inc stock.

Our verdict on BFRG

Not valued: We cannot value this company yet.

We do not publish a value for this company: its filings cover three fiscal years and projecting growth needs four in a row.

ETFs with the most weight in BFRG

Browse

Peers in Health Information Services

All 40 Health Information Services stocks

Cheaper than BFRG in Health Information Services

13 more in this industry show a wider margin of safety.

Is BFRG undervalued or overvalued?

We do not publish a verdict on BFRG yet. A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.

What is the intrinsic value of BFRG?

We do not publish one (as of the 2026-11-17 close). A discounted cash flow projects five years of revenue, so it needs this company’s own growth history: four consecutive fiscal years of accounts, which give three year-on-year growth rates. Its filings on our archive cover three fiscal years so far; the next annual report should close the gap. We could plug in a generic rate, but that would be a valuation of an average company, not of this one.